-+ 0.00%
-+ 0.00%
-+ 0.00%

Kezar Life Sciences Reports Positive Phase 2 Results for Zetomipzomib in Autoimmune Hepatitis and Lupus Nephritis

Reuters·11/07/2025 12:02:24

Please log in to view news